Bendamustine Injection

DRUG2 trials

Sponsors

InnoCare Pharma Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Mantle Cell LymphomaRelapsed/Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymppho

Phase 3

A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL

RecruitingNCT06363994

InnoCare Pharma Inc.Mantle Cell Lymphoma

Start: 2024-05-29End: 2032-06-25Target: 476Updated: 2024-12-27

A Clinical Trial to Evaluate the Efficacy and Safety of TQB3909 Tablets Versus Investigator's Choice in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Not yet recruitingNCT07753369

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Small Lymphocytic Lymppho, Relapsed/Refractory Chronic Lymphocytic Leukemia

Start: 2026-08-01End: 2030-12-01Target: 128Updated: 2026-08-11